期刊
PROGRESS IN RETINAL AND EYE RESEARCH
卷 83, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.preteyeres.2020.100920
关键词
-
资金
- National Institutes of Health [R01EY017607, R01EY023591, R01EY021237, U24EY029891, U01EY025477]
- Foundation Fighting Blindness [PPA-0641-0718-UCSF]
- Gene & Ruth Posner Foundation
- Research to Prevent Blindness
- Claire Giannini Fund
- Lawrence L. Hillblom Foundation
- That Man May See, Inc.
Adaptive optics scanning light ophthalmoscopy (AOSLO) technology allows for high-resolution imaging of the retina, aiding in understanding retinal structure and disease mechanisms. It is currently being used in clinical trials as exploratory measures or biomarkers. Despite not yet being widely adopted in clinical practice, advancements in hardware and software have expanded its use for imaging needs in a broader range of patients.
Adaptive optics scanning light ophthalmoscopy (AOSLO) allows visualization of the living human retina with exquisite single-cell resolution. This technology has improved our understanding of normal retinal structure and revealed pathophysiological details of a number of retinal diseases. Despite the remarkable capabilities of AOSLO, it has not seen the widespread commercial adoption and mainstream clinical success of other modalities developed in a similar time frame. Nevertheless, continued advancements in AOSLO hardware and software have expanded use to a broader range of patients. Current devices enable imaging of a number of different retinal cell types, with recent improvements in stimulus and detection schemes enabling monitoring of retinal function, microscopic structural changes, and even subcellular activity. This has positioned AOSLO for use in clinical trials, primarily as exploratory outcome measures or biomarkers that can be used to monitor disease progression or therapeutic response. AOSLO metrics could facilitate patient selection for such trials, to refine inclusion criteria or to guide the choice of therapy, depending on the presence, absence, or functional viability of specific cell types. Here we explore the potential of AOSLO retinal imaging by reviewing clinical applications as well as some of the pitfalls and barriers to more widespread clinical adoption.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据